Active Learning for Sample-Efficient Protein Design Using Bayesian Uncertainty Estimation and Experimental Feedback

Abstract

Protein design is increasingly mediated by machine learning, yet experimental validation remains expensive, slow, and noisy. This paper examines active learning as a systems strategy for sample-efficient protein design, with particular attention to Bayesian uncertainty estimation and the integration of experimental feedback. Rather than treating uncertainty as a narrow modeling accessory, the discussion positions it as a control signal that governs which proteins are synthesized, assayed, and fed back into the next design cycle. The paper develops a system-level account of closed-loop protein design that spans assay orchestration, data provenance, model maintenance, acquisition policy, robotic execution, and governance. It analyzes key trade-offs between sequential and batched experimentation, computational and wet-lab costs, model calibration and exploration, and local optimization and long-term scientific value. The argument emphasizes that sample efficiency is not only a machine learning property but also an infrastructural, institutional, and policy outcome. Robustness under distribution shift, assay variability, and multi-objective design constraints is considered alongside fairness, biosafety, sustainability, and deployment in resource-constrained settings. Cross-domain comparisons with materials discovery, autonomous laboratories, and clinical machine learning clarify both the promise and the limits of Bayesian active learning. The paper concludes that effective protein design systems require uncertainty-aware models, interoperable data infrastructures, reproducible experimental workflows, and governance mechanisms that align efficiency with safety and equitable benefit. Such systems can reduce experimental waste and accelerate discovery, but only if uncertainty estimation, feedback quality, and institutional accountability are treated as first-class design concerns.